AGGWX
Price
$30.44
Change
+$0.38 (+1.26%)
Updated
Jun 2 closing price
Net Assets
1.69B
FGDCX
Price
$52.46
Change
+$0.62 (+1.20%)
Updated
Jun 2 closing price
Net Assets
4.23B
Interact to see
Advertisement

AGGWX vs FGDCX

Header iconAGGWX vs FGDCX Comparison
Open Charts AGGWX vs FGDCXBanner chart's image
AGGWX vs FGDCX Comparison Chart in %
View a ticker or compare two or three
VS
AGGWX vs. FGDCX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGGWX is a Buy and FGDCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FGDCX has more cash in the bank: 4.23B vs. AGGWX (1.69B). FGDCX pays higher dividends than AGGWX: FGDCX (4.68) vs AGGWX (0.44). AGGWX was incepted earlier than FGDCX: AGGWX (19 years) vs FGDCX (19 years). FGDCX (1.69) is less costly to investors than AGGWX (1.16). FGDCX is a more actively managed with annual turnover of: 60.00 vs. AGGWX (20.00). FGDCX has a lower initial minimum investment than AGGWX: FGDCX (0) vs AGGWX (2500). AGGWX annual gain was more profitable for investors over the last year : 62.11 vs. FGDCX (57.95). AGGWX return over 5 years is better than : 134.48 vs. FGDCX (101.94).
AGGWXFGDCXAGGWX / FGDCX
Total Expense Ratio1.161.6969%
Annual Report Gross Expense Ratio1.161.6969%
Fund Existence19 years19 years-
Gain YTD0.7043.68719%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.69B4.23B40%
Annual Yield % from dividends0.444.689%
Returns for 1 year62.1157.95107%
Returns for 3 years191.91166.43115%
Returns for 5 years134.48101.94132%
Returns for 10 years245.15179.26137%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BHE88.143.11
+3.66%
Benchmark Electronics
MB7.000.08
+1.16%
Masterbeef Group
ROIV28.27-0.82
-2.82%
Roivant Sciences Ltd
BBOT8.24-0.31
-3.63%
BridgeBio Oncology Therapeutics Inc
MGRX0.38-0.04
-8.85%
Mangoceuticals Inc